Skip to main content

Click Here to Register
Browse Schedule
- Full Schedule
- Browse by Date
Browse by Track
Faculty
Keyword Search
Claim Credit
Login required

Login

Home

Psych Congress Main banner

Click Here to Register
Browse Schedule
- Full Schedule
- Browse by Date
Browse by Track
Faculty
Keyword Search
Claim Credit
Login required

Tweets by Psych Congress

Favorite
Facebook
Tweet

Mood Disorders

Psychopharmacology

Psychotherapy

Ketamine-Assisted Psychotherapy: A Practical Guide for Medical Providers

Saturday, September 12, 2020

4:00 PM – 5:00 PM

Presenter(s)

Lynne A. McInnes, MD

Private Practice Psychiatrist
University of California San Francisco
Oakland, California
Jessicca Yu, NP

Psychiatric and Family Nurse Practitioner, Kaiser Permanente
San Francisco, California

Ketamine, an NMDA receptor antagonist, has now been FDA approved for treatment-resistant depression (TRD) in the intranasal form and is also available as an oral, intravenous, and intramuscular agent. This session will describe a rationale for the use of ketamine-assisted psychotherapy (KAP) for TRD, providing a historical context and examples of current theoretical stances. We will discuss which patients are good candidates for this therapy and provide extensive case examples. Practical issues related to KAP, including reimbursement and insurance as well as prevention of medication misuse, will also be addressed.

Designed by CadmiumCD |Technical Support |Give Feedback
© Copyright 2021 CadmiumCD. All Rights Reserved.